1. Screening Libraries
  2. Protein Tyrosine Kinase Compound Library

Protein Tyrosine Kinase Compound Library

Cat. No.: HY-L016
Library Contents: XLSX PDF

A unique collection of 324 protein kinase inhibitors for high throughput screening (HTS) and high content screening (HCS).

Protein Tyrosine Kinase Compound Library
Size (Pre-dissolved DMSO or Solid) Price Stock
30 μL/well (10 mM solution) Get quote In-stock
50 μL/well (10 mM solution) Get quote In-stock
100 μL/well (10 mM solution) Get quote In-stock
250 μL/well (10 mM solution) Get quote In-stock

Please contact us at

[email protected]

Top Publications Citing Use of Products
  • Description

  • Product Details

  • Composition

  • Contents

  • Documentation

Description
& Advantages

•   A unique collection of 324 protein kinase inhibitors for high throughput screening (HTS) and high content screening (HCS).

•   Targets such as VEGFR, ALK, Btk, Bcr-Abl, c-Met/HGFR, EGFR, FGFR, Insulin Receptor, JAK, PDGFR, etc.

•   A useful tool for the research for PTK-related diseases, such as cancer.

•   Bioactivity and safety confirmed by preclinical research and clinical trials. Some protein kinase inhibitors have been approved by FDA.

•   Structurally diverse, medicinally active and cell permeable.

•   Rich documentation with structure, IC50 and summary.

•   NMR and HPLC to ensure the high purity.

•   All compounds are in stock and continuously updated.

Product Details
Formulation:
A collection of 324 protein kinase inhibitors supplied as pre-dissolved DMSO solutions or Solid
Container:
96 Well Format Sample Storage Tube With Screw Cap and Optional 2D Barcode
Storage:
-80°C
Shipping:
Blue ice
Composition

Protein Tyrosine Kinase Compound Library

Source: MedChem Express

Contents of Protein Tyrosine Kinase Compound Library

Plate layout: HY-L016-1

1 2 3 4 5 6 7 8 9 10 11 12
a Empty NT157 EAI045 NVP-BAW2881 AEE788 GSK2256098 Tyrphostin AG 528 NPS-1034 MSDC 0160 LM22A-4 CEP-40783 Empty
b Empty HA-100 Src Inhibitor 1 PD-166866 RG14620 RG13022 ISCK03 SUN11602 Nilotinib Nilotinib (monohydrochloride monohydrate) Btk inhibitor 2 Empty
c Empty Dasatinib Dasatinib (hydrochloride) Linsitinib NVP-TAE 684 BTK IN-1 BMS-754807 Sorafenib Sorafenib (Tosylate) Tandutinib OSI-930 Empty
d Empty Cediranib Amuvatinib Dovitinib (lactate) Pazopanib Masitinib Masitinib (mesylate) CUDC-101 Motesanib Motesanib (Diphosphate) Saracatinib Empty
e Empty RAF265 NVP-ADW742 AG1024 Sunitinib Vandetanib Afatinib Afatinib (dimaleate) BMS-536924 Repotrectinib PD173074 Empty
f Empty Falnidamol CL-387785 Toceranib Regorafenib Regorafenib (monohydrate) Brivanib (alaninate) Brivanib Foretinib KW-2449 KX2-391 (dihydrochloride) Empty
g Empty KX2-391 (Mesylate) Fasudil (Hydrochloride) Canertinib (dihydrochloride) PP121 Semaxinib PD173955 SU 5402 TG101209 PF-562271 (besylate) PF-562271 Empty
h Empty PF-573228 BMS-794833 SU14813 SU14813 (maleate) Orantinib GSK1904529A Telatinib ARRY-380 (analog ) Ningetinib Tosylate Ningetinib Empty

Plate layout: HY-L016-2

1 2 3 4 5 6 7 8 9 10 11 12
a Empty 2-Phospho-L-ascorbic acid trisodium salt EG00229 Lazertinib GW2580 GNF-7 FLT3-IN-1 Tivozanib Lenvatinib ENMD-2076 (Tartrate) ENMD-2076 Empty
b Empty MGCD-265 analog Ibrutinib GNF-2 CGP60474 Nintedanib esylate PHA-665752 R406 (free base) CZC-8004 SM 16 eCF506 Empty
c Empty BMS-986195 ARQ 531 2-D08 CGI-1746 AG-490 Erlotinib (Hydrochloride) Pazopanib (Hydrochloride) BMS-599626 (Hydrochloride) PD153035 (Hydrochloride) SU11274 Empty
d Empty PF-04217903 PF-04217903 (methanesulfonate) Vatalanib (dihydrochloride) SGX-523 WZ4002 AMG-208 Ki8751 Lyn-IN-1 Cabozantinib (S-malate) Ponatinib Empty
e Empty CP-673451 AT7867 AT7867 (dihydrochloride) KRN-633 R406 DPH Lck Inhibitor BMS 777607 Lorlatinib AZ191 Empty
f Empty K02288 Defactinib Defactinib (hydrochloride) WH-4-023 KRCA-0008 UNC2025 UNC2025 (hydrochloride) Gilteritinib Y15 LDC1267 Empty
g Empty ANA-12 Entrectinib BLZ945 BLU9931 Mirk-IN-1 Larotrectinib sulfate TP-0903 SGI-7079 S49076 PRT-060318 Empty
h Empty Quizartinib Alectinib Alectinib Hydrochloride Cabozantinib GSK1838705A Rebastinib Gandotinib Fostamatinib Disodium Fostamatinib disodium hexahydrate Cediranib (maleate) Empty

Plate layout: HY-L016-3

1 2 3 4 5 6 7 8 9 10 11 12
a Empty Sapitinib Golvatinib NVP-TAE 226 Crenolanib Desmethyl Erlotinib NVP-BHG712 CHIR-124 Degrasyn Dacomitinib IRAK inhibitor 1 Empty
b Empty IRAK inhibitor 2 IRAK inhibitor 3 IRAK inhibitor 6 LY2874455 Regorafenib (Hydrochloride) Infigratinib Infigratinib phosphate ASP3026 IRAK-1-4 Inhibitor I AZD4547 Empty
c Empty Apatinib Capmatinib ALK-IN-1 GNF-5837 Mubritinib Piceatannol Nocodazole AG-1478 BPR1J-097 Hydrochloride AZM475271 Empty
d Empty Chrysophanol PQ401 Oglufanide R1530 ZM 306416 PP1 PP2 PLX647 WHI-P154 PD168393 Empty
e Empty CNX-2006 Flumatinib Flumatinib (mesylate) TCS 359 PND-1186 1-Naphthyl PP1 1-Naphthyl PP1 (hydrochloride) CNX-774 DDR1-IN-1 PD153035 Empty
f Empty PF-03814735 Genistein CP-724714 Tepotinib BAY 61-3606 (dihydrochloride) AST 487 Icotinib (Hydrochloride) Icotinib SB1317 TAK-285 Empty
g Empty c-Kit-IN-1 AIM-100 PRT062607 (Hydrochloride) AG 555 ALK inhibitor 2 NVP-BVU972 SAR131675 Imatinib ZM323881 (hydrochloride) Picropodophyllin Empty
h Empty Tyrphostin A9 Merestinib SSR128129E AZD-3463 Tyrphostin 23 Ceritinib Ceritinib dihydrochloride GZD824 Rociletinib Rociletinib hydrobromide Empty

Plate layout: HY-L016-4

1 2 3 4 5 6 7 8 9 10 11 12
a Empty Poziotinib GNF-5 XL228 A 419259 (trihydrochloride) Tirabrutinib Tirabrutinib (hydrochloride) Osimertinib Osimertinib mesylate UNC2250 UNC2881 Empty
b Empty ID-8 CEP-37440 AMG 925 (HCl) Entospletinib H-89 (dihydrochloride) Cerdulatinib Irbinitinib AT13148 JI-101 Pacritinib Empty
c Empty Butein Pexidartinib Sitravatinib Acalabrutinib Belizatinib LFM-A13 Spebrutinib CEP-28122 (mesylate salt) CCT241736 AZD2932 Empty
d Empty GW 441756 FIIN-2 PD158780 AMG-337 Erdafitinib SCR-1481B1 AZD3759 ONO-4059 (analog) NVP-ACC789 MCB-613 Empty
e Empty Olmutinib EGFR-IN-3 Avitinib (maleate) Fenebrutinib PF06650833 Fruquintinib CH5183284 PF-06459988 Tyrphostin AG 879 Pelitinib Empty
f Empty Neratinib JNJ-38877605 Tivantinib Linifanib Bafetinib Crizotinib Crizotinib (hydrochloride) Gefitinib Gefitinib (hydrochloride) Erlotinib Empty
g Empty Lapatinib Lapatinib (ditosylate) Nintedanib Dovitinib Imatinib (Mesylate) Tolimidone MNS Bucladesine (sodium salt) Bucladesine (calcium salt) SU6656 Empty
h Empty Altiratinib AZ-5104 Trapidil Chloropyramine hydrochloride Metadoxine Ginsenoside Rb1 Ferulic acid Neohesperidin dihydrochalcone Formononetin Harmine Empty

Plate layout: HY-L016-5

1 2 3 4 5 6 7 8 9 10 11 12
a Empty Scutellarein 7-Hydroxy-4H-chromen-4-one Protein kinase inhibitors 1 hydrochloride 2,5-Dihydroxybenzoic acid Empty Empty Empty Empty Empty Empty Empty
b Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty
c Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty
d Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty
e Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty
f Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty
g Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty
h Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty
Documentation

Inquiry Online

Your information is safe with us. * Required Fields.

Product name

 

Salutation

Applicant name *

 

Email address *

Phone number *

 

Organization name *

Country or Region *

 

Requested quantity *

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Protein Tyrosine Kinase Compound Library
Cat. No.:
HY-L016
Quantity:

Request SDF File

Please enter your email address. We will send your requested SDF file to you as soon as possible.